Caption Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-242,800
Closed -$21.2M 1784
2021
Q4
$21.2M Buy
+242,800
New +$20.2M 0.24% 87
2021
Q3
Sell
-73,000
Closed -$6.66M 1703
2021
Q2
$6.66M Buy
+73,000
New +$6.5M 0.09% 300

Other funds holding NVS

Caption Management's NVS Position: Q3 2024 in Review

Caption Management sold out of Novartis (NVS) in Q3 2024, closing a stake of 7,500 shares — an estimated $798K sold.

Caption Management first reported a position in NVS in Q1 2020 and held it in 7 quarters. The position peaked at $8.31M in Q4 2021. 1,311 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

  • Caption Management reported no remaining Novartis position as of Q3 2024 after selling out during the quarter.
  • Caption Management sold 7,500 Novartis shares in Q3 2024, an estimated $798K.
  • Caption Management first reported a position in Novartis in Q1 2020 and held it in 7 quarters.
  • Caption Management's Novartis position peaked at $8.31M in Q4 2021.
  • 1,311 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.